{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:53:07Z","timestamp":1786989187776,"version":"build-2736575974"},"reference-count":160,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.fjurol.2024.102722","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T22:58:06Z","timestamp":1732229886000},"page":"102722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0Update 2024\u20132026: Upper urinary tract urothelial cancer (UTUC)"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-146X","authenticated-orcid":false,"given":"Mathieu","family":"Roumigui\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Masson-Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriane","family":"Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5526-077X","authenticated-orcid":false,"given":"Y.","family":"Allory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8444-3295","authenticated-orcid":false,"given":"Priscilla","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Bajeot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Prad\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1806-1448","authenticated-orcid":false,"given":"Gautier","family":"Marcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-2075","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Audenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fjurol.2024.102722_bib0805","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.fjurol.2024.102722_bib0810","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1007\/s00345-020-03576-3","article-title":"Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study","volume":"39","author":"Alm\u00e5s","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0815","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.purol.2014.06.012","article-title":"Epidemiology and risk factors for tumours of the upper urinary excretory tract: a review of the literature for the annual report of the French Urology Association","volume":"24","author":"Ouzzane","year":"2014","journal-title":"Progres En Urol J Assoc"},{"key":"10.1016\/j.fjurol.2024.102722_bib0820","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0825","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2007.06841.x","article-title":"Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments","volume":"100","author":"Sanderson","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib0830","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.1998.16.3.1099","article-title":"Extravesical tumor relapse in patients with superficial bladder tumors","volume":"16","author":"Herr","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0835","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.urolonc.2018.02.009","article-title":"Upper tract urothelial carcinoma following intravesical bacillus Calmette-Gu\u00e9rin therapy for nonmuscle-invasive bladder cancer: results from a multi-institutional retrospective study","volume":"36","author":"Nishiyama","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0840","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","article-title":"A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma","volume":"67","author":"Seisen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0845","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.eururo.2012.06.029","article-title":"Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy","volume":"63","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0850","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib0855","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nephro.2015.10.001","article-title":"[Aristolochic acid nephropathy (\u201cChinese herb nephropathy\u201d)]","volume":"11","author":"Nortier","year":"2015","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.fjurol.2024.102722_bib0860","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7326\/0003-4819-158-6-201303190-00006","article-title":"The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review","volume":"158","author":"G\u00f6kmen","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib0865","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.2147\/CMAR.S178554","article-title":"Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients","volume":"10","author":"Xiong","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.fjurol.2024.102722_bib0870","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fonc.2019.00157","article-title":"Gender is a significant prognostic factor for upper tract urothelial carcinoma: a large hospital-based cancer registry study in an endemic area","volume":"9","author":"Huang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0875","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1464-410X.2008.07565.x","article-title":"Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan","volume":"102","author":"Tan","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib0880","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/oemed-2013-101443","article-title":"Arsenic in drinking water and renal cancers in rural Bangladesh","volume":"70","author":"Mostafa","year":"2013","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib0885","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1470-2045(09)70041-5","article-title":"Management of extracolonic tumours in patients with Lynch syndrome","volume":"10","author":"Koornstra","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0890","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib0895","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fjurol.2024.102722_bib0900","doi-asserted-by":"crossref","first-page":"E583","DOI":"10.1111\/j.1464-410X.2012.11298.x","article-title":"A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool","volume":"110","author":"Audenet","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib0905","doi-asserted-by":"crossref","DOI":"10.1111\/bju.16405","article-title":"A Collaborative Review of the Microsatellite Instability\/Deficient Mismatch Repair Phenotype in Patients with Upper Tract Urothelial Carcinoma","author":"Gabriel","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib0910","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/PAS.0000000000001141","article-title":"Universal Lynch syndrome screening should be performed in all upper tract urothelial carcinomas","volume":"42","author":"Ju","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0915","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2017.08.002","article-title":"Universal point of care testing for lynch syndrome in patients with upper tract urothelial carcinoma","volume":"199","author":"Metcalfe","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0920","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the Eighth Edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0925","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.purol.2014.07.003","article-title":"Anatomopathology of tumours of the upper urinary excretory tract: state of the art for the annual report of the French Urology Association","volume":"24","author":"Varinot","year":"2014","journal-title":"Progres En Urol J Assoc"},{"key":"10.1016\/j.fjurol.2024.102722_bib0930","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jso.25877","article-title":"Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract","volume":"121","author":"Rosiello","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0935","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.juro.2012.04.009","article-title":"Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma","volume":"188","author":"Rink","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0940","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bju.14751","article-title":"Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy","volume":"124","author":"Zamboni","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib0945","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejrad.2017.10.021","article-title":"Upper tract urothelial cancer","volume":"98","author":"Froemming","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0950","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.purol.2014.07.009","article-title":"Imaging upper excretory tract tumours: state of the art for the annual scientific report of the French Urology Association","volume":"24","author":"Puech","year":"2014","journal-title":"Progres En Urol J Assoc"},{"key":"10.1016\/j.fjurol.2024.102722_bib0955","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ucl.2017.12.001","article-title":"Current staging strategies for muscle-invasive bladder cancer and upper tract urothelial cell carcinoma","volume":"45","author":"Mossanen","year":"2018","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.fjurol.2024.102722_bib0960","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00330-019-06529-6","article-title":"Imaging protocols for CT urography: results of a consensus conference from the French Society of Genitourinary Imaging","volume":"30","author":"Renard-Penna","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0965","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1464-410X.2007.06766.x","article-title":"Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour","volume":"99","author":"Cowan","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib0970","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejrad.2008.10.026","article-title":"Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis","volume":"73","author":"Chlapoutakis","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0975","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/iju.13032","article-title":"Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma","volume":"23","author":"Jinzaki","year":"2016","journal-title":"Int J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0980","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00345-019-02875-8","article-title":"Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis","volume":"38","author":"Janisch","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0985","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejrad.2017.10.021","article-title":"Upper tract urothelial cancer","volume":"98","author":"Froemming","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0990","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/iju.14068","article-title":"Clinical staging of upper urinary tract urothelial carcinoma for T staging: review and pictorial essay","volume":"26","author":"Honda","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib0995","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2214\/AJR.14.13167","article-title":"T categorization of urothelial carcinomas of the ureter with CT: preliminary study of new diagnostic criteria proposed for differentiating T2 or lower from T3 or higher","volume":"204","author":"Honda","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1000","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.juro.2009.12.031","article-title":"Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy","volume":"183","author":"Takahashi","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.12.002","article-title":"Trends in the utilization of imaging for upper tract urothelial carcinoma","volume":"34","author":"Mohapatra","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1010","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1007\/s00261-019-02085-1","article-title":"Update on MR urography (MRU): technique and clinical applications","volume":"44","author":"Abreu-Gomez","year":"2019","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.fjurol.2024.102722_bib1015","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00330-019-06530-z","article-title":"Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging","volume":"30","author":"Rouvi\u00e8re","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1020","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.05.0172","article-title":"Gadolinium-enhanced fat-suppressed T1-weighted imaging for staging ureteral carcinoma: correlation with histopathology","volume":"188","author":"Obuchi","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1025","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2214\/AJR.10.6299","article-title":"Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI","volume":"197","author":"Akita","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1030","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s00261-017-1116-5","article-title":"The value of adding diffusion-weighted images for tumor detection and preoperative staging in renal pelvic carcinoma for the reader's experience","volume":"42","author":"Yoshida","year":"2017","journal-title":"Abdom Radiol N Y"},{"key":"10.1016\/j.fjurol.2024.102722_bib1035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.purol.2014.07.012","article-title":"Clinical, ureteroscopic and photodynamic diagnosis of tumours of the upper urinary excretory tract: state of the art for the annual scientific report of the French Urology Association","volume":"24","author":"Nison","year":"2014","journal-title":"Progres En Urol J Assoc"},{"key":"10.1016\/j.fjurol.2024.102722_bib1040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jasc.2021.12.003","article-title":"We\u2019ll always have Paris The Paris System for Reporting Urinary Cytology 2022","volume":"11","author":"Wojcik","year":"2022","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1055","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejso.2020.06.024","article-title":"Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: systematic review and meta-analysis","volume":"46","author":"Subiela","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1060","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.juro.2018.02.002","article-title":"Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma","volume":"199","author":"Margolin","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bju.13935","article-title":"Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis","volume":"120","author":"Marchioni","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bju.14053","article-title":"Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis","volume":"121","author":"Guo","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00345-019-02768-w","article-title":"Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage","volume":"38","author":"Baboudjian","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4111\/icu.2020.61.2.158","article-title":"Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer","volume":"61","author":"Chung","year":"2020","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1085","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00345-019-02675-0","article-title":"Which flexible ureteroscope is the best for upper tract urothelial carcinoma treatment?","volume":"37","author":"Keller","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1090","doi-asserted-by":"crossref","first-page":"101617","DOI":"10.1016\/j.pdpdt.2019.101617","article-title":"5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma\u00a0\u223c\u00a0preliminary prospective single centre trial","volume":"29","author":"Fukuhara","year":"2020","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.fjurol.2024.102722_bib1095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/end.2009.0593","article-title":"Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience","volume":"25","author":"Traxer","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1590\/s1677-5538.ibju.2016.0324","article-title":"Evaluation of the Spies TM modalities image quality","volume":"43","author":"Emiliani","year":"2017","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1105","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.euf.2017.05.008","article-title":"Correlation Between Confocal Laser Endomicroscopy (Cellvizio\u00ae) and histological grading of upper tract urothelial carcinoma: a step forward for a better selection of patients suitable for conservative management","volume":"4","author":"Breda","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102722_bib1110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.purol.2021.10.007","article-title":"Comparison of Irrigation Flows between Different Irrigation Methods for Flexible Ureteroscopy: An in Vitro Study","volume":"32","author":"Grinholtz","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/end.2015.0387","article-title":"Can we provide low intrarenal pressures with good irrigation flow by decreasing the size of ureteral access sheaths?","volume":"30","author":"Sener","year":"2016","journal-title":"J Endourol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1120","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bju.14389","article-title":"Systematic review of ureteral access sheaths: facts and myths","volume":"122","author":"De Coninck","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2021.11.026","article-title":"Bladder recurrence following diagnostic ureteroscopy in patients undergoing nephroureterectomy for upper tract urothelial cancer: is ureteral access sheath protective?","volume":"160","author":"Douglawi","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102722_bib1130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.6004\/jnccn.2020.7637","article-title":"Sex- and age-related differences in the distribution of metastases in patients with upper urinary tract urothelial carcinoma","volume":"19","author":"Deuker","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.fjurol.2024.102722_bib1135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/JU.0000000000003085","article-title":"Diagnostic accuracy of clinical lymph node staging for upper tract urothelial cancer patients: a multicenter, retrospective, observational study","volume":"209","author":"Pallauf","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000318985","article-title":"Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society","volume":"85","author":"Heidenreich","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.euo.2019.09.004","article-title":"Diagnostic Value of 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma","volume":"3","author":"Voskuilen","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000381269","article-title":"Clinical Value of 18F-Fluorodeoxyglucose positron emission tomography\/computed tomography in upper tract urothelial carcinoma: impact on detection of metastases and patient management","volume":"96","author":"Tanaka","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejrad.2015.12.017","article-title":"FDG-PET\/CT as a post-treatment restaging tool in urothelial carcinoma: comparison with contrast-enhanced CT","volume":"85","author":"Kitajima","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1160","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s00261-017-1443-6","article-title":"Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study","volume":"43","author":"Zattoni","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.purol.2014.07.013","article-title":"Prognostic factors of upper excretory tract tumours and impact on survival: a systematic review for the annual report of the French Urology Association","volume":"24","author":"Colin","year":"2014","journal-title":"Progres En Urol J Assoc"},{"key":"10.1016\/j.fjurol.2024.102722_bib1170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2013.12.007","article-title":"A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUC) in a predefinitive treatment setting: low-risk versus high-risk UTUC","volume":"66","author":"Roupr\u00eat","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1175","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.eururo.2021.05.004","article-title":"Pretreatment risk stratification for endoscopic kidney-sparing surgery in upper tract urothelial carcinoma: an international collaborative study","volume":"80","author":"Foerster","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.euf.2021.03.018","article-title":"Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney-sparing strategies: an International Collaborative Study","volume":"8","author":"Marcq","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102722_bib1185","article-title":"Novel nomograms to predict muscle invasion and lymph node metastasis in upper tract urothelial carcinoma","volume":"40","author":"Venkat","year":"2022","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.fjurol.2024.102722_bib1190","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.fjurol.2024.102722_bib1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.12.002","article-title":"Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma","volume":"37","author":"Petros","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1200","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1002\/cam4.2988","article-title":"Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma","volume":"9","author":"Yoshida","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib1205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bju.12631","article-title":"Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and\/or locally advanced upper tract urothelial carcinoma without metastasis","volume":"114","author":"Seisen","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2016.07.036","article-title":"Prognostic factors of overall survival in upper urinary tract carcinoma: a systematic review and meta-analysis","volume":"100","author":"Petrelli","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102722_bib1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.12.027","article-title":"Development and external validation of a nomogram predicting prognosis of upper tract urothelial carcinoma after radical nephroureterectomy","volume":"37","author":"Zeng","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1220","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/bjc.2012.64","article-title":"Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram","volume":"106","author":"Yates","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fjurol.2024.102722_bib1225","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/bjc.2013.462","article-title":"External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma","volume":"109","author":"Ku","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fjurol.2024.102722_bib1230","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","article-title":"Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1235","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","article-title":"Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic Review by the EAU non-muscle invasive bladder cancer guidelines panel","volume":"70","author":"Seisen","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1240","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12885-018-4118-y","article-title":"Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study","volume":"18","author":"Wen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.fjurol.2024.102722_bib1245","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1089\/end.2019.0308","article-title":"Thulium-Holmium: YAG Duo Laser in conservative upper tract urothelial cancer treatment: 13 years experience from a tertiary national referral center","volume":"33","author":"Defidio","year":"2019","journal-title":"J Endourol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1250","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.purol.2014.07.007","article-title":"Conservative treatment of upper excretory tract tumours: systematic literature review for the annual scientific report of the French Urology Association","volume":"24","author":"Pignot","year":"2014","journal-title":"Progres En Urol J Assoc"},{"key":"10.1016\/j.fjurol.2024.102722_bib1255","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00345-015-1753-7","article-title":"Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings","volume":"34","author":"Villa","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1260","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bju.14697","article-title":"Segmental resection of distal ureter with termino-terminal ureteric anastomosis vs bladder cuff removal and ureteric re-implantation for upper tract urothelial carcinoma: results of a multicentre study","volume":"124","author":"Abrate","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4081\/aiua.2021.1.101","article-title":"Robot-assisted segmental ureterectomy with psoas hitch ureteral reimplantation: oncological, functional and perioperative outcomes of case series of a single centre","volume":"93","author":"Palagonia","year":"2021","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.fjurol.2024.102722_bib1270","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1470-2045(20)30147-9","article-title":"Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial","volume":"21","author":"Kleinmann","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1275","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/JU.0000000000002350","article-title":"Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report","volume":"207","author":"Matin","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00345-012-0949-3","article-title":"Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes","volume":"31","author":"Audenet","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1285","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.urolonc.2019.02.004","article-title":"Endocavitary treatment for upper tract urothelial carcinoma: a meta-analysis of the current literature","volume":"37","author":"Foerster","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1290","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/end.2019.0750","article-title":"Adjuvant single-dose upper urinary tract instillation of mitomycin C after therapeutic ureteroscopy for upper tract urothelial carcinoma: a single-centre prospective non-randomized trial","volume":"34","author":"Gallioli","year":"2020","journal-title":"J Endourol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1295","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/JU.0000000000003185","article-title":"Efficacy and safety of mitomycin gel (UGN-101) as an adjuvant therapy after complete endoscopic management of upper tract urothelial carcinoma","volume":"209","author":"Labbate","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1300","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.euf.2023.03.016","article-title":"Mitomycin Gel (UGN-101) as a kidney-sparing treatment for upper tract urothelial carcinoma in patients with imperative indications and high-grade disease","volume":"9","author":"Rose","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102722_bib1305","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.purol.2014.07.008","article-title":"Surgical treatment of tumours of the upper excretory tract by total nephro-ureterectomy: state of the art for the annual report of the French Association of Urology","volume":"24","author":"Neuzillet","year":"2014","journal-title":"Progres En Urol J Assoc"},{"key":"10.1016\/j.fjurol.2024.102722_bib1310","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/jjco\/hyx085","article-title":"Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial","volume":"47","author":"Yamashita","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.euf.2017.10.003","article-title":"Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: a European Association of Urology Guidelines systematic review","volume":"5","author":"Peyronnet","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102722_bib1320","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.eururo.2011.12.026","article-title":"Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series","volume":"61","author":"Hanna","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1325","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.euf.2017.10.003","article-title":"Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma","volume":"5","author":"Peyronnet","year":"2019","journal-title":"Eur Assoc Urol Guidel Syst Rev Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102722_bib1330","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.eururo.2011.12.026","article-title":"Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series","volume":"61","author":"Hanna","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1335","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2009.06.013","article-title":"Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study","volume":"56","author":"Simone","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1340","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1245\/s10434-023-13221-z","article-title":"Comparison of perioperative outcomes and complications of laparoscopic and robotic nephroureterectomy approaches in patients with upper-tract urothelial carcinoma","volume":"30","author":"Peng","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1345","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00345-019-03020-1","article-title":"Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases","volume":"38","author":"Veccia","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1350","doi-asserted-by":"crossref","first-page":"101607","DOI":"10.3390\/cancers15051409","article-title":"Comparing Oncological and Perioperative Outcomes of Open Versus Laparoscopic Versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis","volume":"15","author":"Grossmann","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.fjurol.2024.102722_bib1355","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15204926","article-title":"Oncological Efficacy of Robotic Nephroureterectomy Vs. Open and Laparoscopic Nephroureterectomy for Suspected Non-Metastatic Utuc-a Systematic Review and Meta-Analysis","volume":"15","author":"Rajan","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.fjurol.2024.102722_bib1360","first-page":"S737","article-title":"Comparing oncological and perioperative outcomes of open versus laparoscopic versus robotic radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: a multicenter, multinational, propensity score-matched analysis","volume":"83","author":"Grossman","year":"2023"},{"key":"10.1016\/j.fjurol.2024.102722_bib1365","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.3390\/cancers15204926","article-title":"Oncological efficacy of robotic nephroureterectomy vs. open and laparoscopic nephroureterectomy for suspected non-metastatic UTUC\u00a0-\u00a0a systematic review and meta-analysis","volume":"15","author":"Rajan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.fjurol.2024.102722_bib1370","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2010.01.043","article-title":"Should urologists always perform a bladder cuff resection during nephroureterectomy, and which method should they use?","volume":"57","author":"Zlotta","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1375","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","article-title":"Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1380","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00345-016-1764-z","article-title":"Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma","volume":"35","author":"Seisen","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1385","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.euf.2017.09.015","article-title":"Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the European association of urology guidelines panel on non-muscle-invasive bladder cancer","volume":"5","author":"Dominguez-Escrig","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102722_bib1390","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1442-2042.2012.03009.x","article-title":"Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract","volume":"19","author":"Kondo","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1395","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.juro.2015.06.077","article-title":"Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates","volume":"194","author":"Matin","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1400","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2005.03.009","article-title":"Upper urinary tract cancer: location is correlated with prognosis","volume":"48","author":"van der Poel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1405","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1111\/j.1464-410X.2012.11199.x","article-title":"Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours","volume":"110","author":"Bin","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1410","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0022-5347(17)47305-8","article-title":"The architecture of the musculature of the guinea-pig ureter as examined by scanning electron microscopy","volume":"134","author":"Tachibana","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1415","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.3390\/cancers14215452","article-title":"Oncological outcomes of distal ureterectomy for high-risk urothelial carcinoma: a multicenter study by the French Bladder Cancer Committee","volume":"14","author":"Masson-Lecomte","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.fjurol.2024.102722_bib1420","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.ejso.2016.08.008","article-title":"A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma","volume":"42","author":"Fang","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1425","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.clgc.2019.10.015","article-title":"Segmental ureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies","volume":"18","author":"Veccia","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.fjurol.2024.102722_bib1430","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.juro.2017.07.088","article-title":"Which patients with upper tract urothelial carcinoma can be safely treated with flexible ureteroscopy with Holmium:YAG laser photoablation? Long-term results from a high volume institution","volume":"199","author":"Villa","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1435","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","article-title":"Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy","volume":"112","author":"Xylinas","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102722_bib1440","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","article-title":"Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy","volume":"79","author":"Leow","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1445","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1450","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.22.00763","article-title":"Multicenter Phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma","volume":"41","author":"Coleman","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1455","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clgc.2021.12.014","article-title":"Five and ten-year outcomes of neoadjuvant chemotherapy and surgery for high-risk upper tract urothelial carcinoma","volume":"20","author":"Adibi","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.fjurol.2024.102722_bib1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.05.014","article-title":"A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02","volume":"40","author":"Necchi","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1465","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"O\u2019Brien","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1470","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial","volume":"31","author":"Ito","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1475","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.fjurol.2024.102722_bib1480","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant Atezolizumab Versus Observation in Muscle-Invasive Urothelial Carcinoma (Imvigor010): A Multicentre, Open-Label, Randomised, Phase 3 Trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1485","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","article-title":"Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma","volume":"35","author":"Seisen","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1490","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1495","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib1500","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/j.prro.2021.02.005","article-title":"Predictors of locoregional recurrence and delineation of adjuvant radiation therapy fields for patients with upper tract urothelial carcinoma receiving nephroureterectomy","volume":"11","author":"Gao","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1505","first-page":"4051","article-title":"Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract","volume":"36","author":"Hahn","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.fjurol.2024.102722_bib1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.07.029","article-title":"Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study","volume":"40","author":"Shigeta","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1515","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib1520","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib1525","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa2309863","article-title":"Nivolumab plus gemcitabine-cisplatin in advanced urothelial carcinoma","volume":"389","author":"van der Heijden","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib1530","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa2002788","article-title":"Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma","volume":"383","author":"Powles","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib1535","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1200\/JCO.22.01792","article-title":"Avelumab first-line maintenance for advanced urothelial carcinoma: results from the JAVELIN Bladder 100 trial after \u22652 years of follow-up","volume":"41","author":"Powles","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1540","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1200\/JCO.2011.34.8433","article-title":"Treatment of patients with metastatic urothelial cancer \u201cunfit\u201d for cisplatin-based chemotherapy","volume":"29","author":"Galsky","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1545","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/annonc\/mdr156","article-title":"Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma","volume":"23","author":"Galsky","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1550","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/annonc\/mdz214","article-title":"Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive\/Advanced Cancer of the Urothelium (RISC)","volume":"30","author":"Bamias","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1555","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(20)30230-0","article-title":"Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"395","author":"Galsky","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.fjurol.2024.102722_bib1560","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S1470-2045(20)30541-6","article-title":"Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial","volume":"21","author":"Powles","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1565","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial","volume":"22","author":"Powles","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1570","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa2308849","article-title":"Erdafitinib or chemotherapy in advanced or metastatic urothelial carcinoma","volume":"389","author":"Loriot","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib1575","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab vedotin in previously treated advanced urothelial carcinoma","volume":"384","author":"Powles","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102722_bib1580","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1470-2045(21)00660-4","article-title":"Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study","volume":"23","author":"Siefker-Radtke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1585","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ejca.2012.01.022","article-title":"Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen","volume":"48","author":"Edeline","year":"2012","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.fjurol.2024.102722_bib1590","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.purol.2015.05.012","article-title":"Surveillance of urothelial carcinomas: a review by the Oncology Committee of the French Urology Association","volume":"25","author":"Colin","year":"2015","journal-title":"Prog En Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1595","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.eururo.2014.08.003","article-title":"Conditional survival after radical nephroureterectomy for upper tract carcinoma","volume":"67","author":"Ploussard","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102722_bib1600","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2022.04.003","article-title":"Oncologic surveillance after radical nephroureterectomy for high-risk upper tract urothelial carcinoma","author":"Martini","year":"2022","journal-title":"Eur Urol Oncol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024001797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024001797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T22:59:21Z","timestamp":1732229961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393024001797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":160,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2950393024001797"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102722","relation":{},"ISSN":["2950-3930"],"issn-type":[{"value":"2950-3930","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0Update 2024\u20132026: Upper urinary tract urothelial cancer (UTUC)","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102722"}}